Cardiovascular diseases and osteoarthritis: general mechanisms of development, prospects for combined prevention and therapy
https://doi.org/10.15829/1728-8800-2021-2660
Abstract
A critical analysis of the study’s results on the relationship of cardiovascular diseases and osteoarthritis is carried out. An assessment of the possibility of their combined prevention and treatment is given. The analysis of experimental, clinical and large-scale studies of recent years allows to put forward a well-founded concept, according to which the joint tissues are the target organ for a number of cardiovascular factors. Hypertension, hyperlipidemia, and obesity are among the most significant risk factors for degenerative joint diseases. In a number of studies, the primary role of these factors in the pathogenesis of osteoarthritis has been established, and therefore an attempt has been made to clinically classify cardiovascular comorbidity in osteoarthritis. Currently, there are reasons to believe that active non-pharmacological and pharmacological correction of cardiovascular factors can be used in the treatment of osteoarthritis.
About the Authors
M. A. Kabalyk
Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
V. A. Nevzorova
Pacific State Medical University
Russian Federation
Russian Federation
Vladivostok
References
1. Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. (In Russ.) doi:10.15829/1728-8800-2019-1-5-66.
2. Golightly YM, Jordan JM, Nelson AE, et al. Contributions of symptomatic osteoarthritis and physical function to incident cardiovascular disease. BMC Musculoskelet Disord. 2018;19(1):393. doi:10.1186/s12891-018-2311-4.
3. Fernandes GS, Valdes AM. Cardiovascular disease and osteoarthritis: common pathways and patient outcomes. Eur J Clin Invest. 2015;45(4):405-14. doi:10.1111/eci.12413.
4. Kabalyk MA, Nevzorova VA, Dubov VS, et al. Molecular and cellular effects of intraarticular injection of betamethasone in experimental osteoarthritis. Genij Ortopedii. 2020;26(1):65-71. (In Russ.) doi:10.18019/1028-4427-2020-26-1-65-71.
5. Menon J, Mishra P. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. Osteoarthr Cartil. 2018;26(4):480-4. doi:10.1016/j.joca.2017.12.007.
6. Francisco V, Ruiz-Fernandez C, Pino J, et al. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196-206. doi:10.1016/j.bcp.2019.03.030.
7. Popov AA, Izmozherova NV, Oboskalova TA. A one-step study of multimorbid pathology in women with estrogen deficiency. Ural Medical Journal. 2020;6:69-76. (In Russ.) doi: 10.25694/URMJ.2020.06.16.
8. Smith KB, Smith MS. Obesity Statistics. Prim Care. 2016;43(1):121-35. doi:10.1016/j.pop.2015.10.001.
9. Courties A, Gualillo O, Berenbaum F, Sellam J. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1955-65. doi:10.1016/j.joca.2015.05.016.
10. Belluzzi E, El Hadi H, Granzotto M, et al. Systemic and Local Adipose Tissue in Knee Osteoarthritis. J Cell Physiol. 2017;232(8):1971-8. doi:10.1002/jcp.25716.
11. Lee BJ, Yang S, Kwon S, et al. Association between metabolic syndrome and knee osteoarthritis: A cross-sectional nationwide survey study. J Rehabil Med. 2019;51(6):464-70. doi:10.2340/16501977-2561.
12. Niu J, Clancy M, Aliabadi P, et al. Metabolic Syndrome, Its Components, and Knee Osteoarthritis: The Framingham Osteoarthritis Study. Arthritis Rheumatol. 2017;69(6):1194-203. doi:10.1002/art.40087.
13. Hussain SM, Wang Y, Cicuttini FM, et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study. Semin Arthritis Rheum. 2014;43(4):429-36. doi:10.1016/j.semarthrit.2013.07.013.
14. Yoshimura N, Muraki S, Oka H, et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage. 2012;20(11):1217-26. doi:10.1016/j.joca.2012.06.006.
15. Trifonova ES, Korneva KG, Grunina EA, et al. Factors affecting the progression of osteoarthritis of the knee joints in patients with type 2 diabetes. Ural Medical Journal. 2013;3:49-52. (In Russ.)
16. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 2005;44(1):7-16. doi:10.1093/rheumatology/keh344.
17. Hall AJ, Stubbs B, Mamas MA, et al. Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):938-46. doi:10.1177/2047487315610663.
18. Kim HS, Shin JS, Lee J, et al. Association between Knee Osteoarthritis, Cardiovascular Risk Factors, and the Framingham Risk Score in South Koreans: A Cross-Sectional Study. PLoS One. 2016;11(10):e0165325. doi:10.1371/journal.pone.0165325.
19. Bae YH, Shin JS, Lee J, et al. Association between Hypertension and the Prevalence of Low Back Pain and Osteoarthritis in Koreans: A Cross-Sectional Study. PLoS One. 2015;10(9):e0138790. doi:10.1371/journal.pone.0138790.
20. Zhang YM, Wang J, Liu XG. Association between hypertension and risk of knee osteoarthritis: A meta-analysis of observational studies. Medicine (Baltimore). 2017;96(32):e7584. doi:10.1097/MD.0000000000007584.
21. Lo GH, McAlindon TE, Katz JN, et al. Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative. Clin Rheumatol. 2017;36(9):2121-8. doi:10.1007/s10067-017-3656-z.
22. Yasuda E, Nakamura R, Matsugi R, et al. Association between the severity of symptomatic knee osteoarthritis and cumulative metabolic factors. Aging Clin Exp Res. 2018;30(5):481-4. doi:10.1007/s40520-017-0808-6.
23. Wen CY, Chen Y, Tang HL, et al. Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus. Osteoarthr Cartil. 2013;21(11):1716-23. doi:10.1016/j.joca.2013.06.027.
24. Kabalyk MA, Kovalenko TS, Nevzorova VA, Sukhanova GI. Effect of arterial hypertension and hyperlipidemia on remodeling of articular cartilage and the development of osteoarthritis (experimental study). Adv Gerontol. 2019;32(4):550-7. (In Russ.)
25. Kabalyk MA, Nevzorova VA, Kovalenko TS, Sukhanova GI. Endothelium-dependent molecular mechanisms of articular cartilage and subchondral bone remodeling in conditions of cardiovascular comorbidity. Cardiovascular Therapy and Prevention. 2019;18(5):102-7. (In Russ.) doi:10.15829/1728-8800-2019-5-102-107.
26. Al-Khazraji BK, Appleton CT, Beier F, et al. Osteoarthritis, cerebrovascular dysfunction and the common denominator of inflammation: a narrative review. Osteoarthr Cartil. 2018;26(4):462-70. doi:10.1016/j.joca.2018.01.01.
27. Tootsi K, Kals J, Zilmer M, et al. Severity of Osteoarthritis Is Associated with Increased Arterial Stiffness. Int J Rheumatol. 2016;2016:6402963. doi:10.1155/2016/6402963.
28. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology (Oxford). 2007;46(12):1763-8. doi:10.1093/rheumatology/kem191.
29. Kabalyk MA. Relationship between vascular remodeling and structural progression of osteoarthritis. Bulletin of the Smolensk State Medical Academy. 2018;17(1):99-105. (In Russ.)
30. Saito T, Fukai A, Mabuchi A, et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med. 2010;16(6):678-86. doi:10.1038/nm.2146.
31. Kabalyk MA, Plekhova NG, Lagureva AV, Sunyaikin AB. Clinical and pathogenetic relationships of molecular regulation of apoptosis and cell differentiation in osteoarthritis. Kazan Medical Journal. 2018;99(1):30-6. (In Russ.) doi:10.17816/KMJ2018-030.
32. Pufe T, Kurz B, Petersen W, et al. The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system. Ann Anat. 2005;187(5-6):461-72. doi:10.1016/j.aanat.2005.06.008.
33. Tenti S, Pascarelli NA, Cheleschi S, et al. The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications. Curr Rheumatol Rev. 2016;12(3):177-84. doi:10.2174/157339711266616033114330.
34. Haywood L, McWilliams DF, Pearson CI, et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 2003;48(8):2173-7. doi:10.1002/art.11094.
35. Dahaghin S, Bierma-Zeinstra SM, Koes BW, et al. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis. 2007;66(7):916-20. doi:10.1136/ard.2005.045724.
36. Cominacini L, Rigoni A, Pasini AF, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem. 2001;276(17):13750-5. doi:10.1074/jbc.M010612200.
37. Nishimura S, Akagi M, Yoshida K, et al. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthr Cartil. 2004;12(7):568-76. doi:10.1016/j.joca.2004.04.005.
38. Hashimoto K, Mori S, Oda Y, et al. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis. Scand J Rheumatol. 2016;45(5):412-22. doi:10.3109/03009742.2015.1135979.
39. Davies-Tuck ML, Hanna F, Davis SR, et al. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women — a prospective cohort study. Arthritis Res Ther. 2009;11(6):R181. doi:10.1186/ar2873.
40. Farnaghi S, Prasadam I, Cai G, et al. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis. FASEB J. 2017;31(1):356-67. doi:10.1096/fj.201600600R.
41. Ktsoeva AA. The role of cartilage glycoprotein-39 in patients with osteoarthritis of the knee joint in combination with ischemic heart disease, arterial hypertension and dyslipidemia. Therapy. 2018;3(21):72-7. (In Russ.)
42. Matveeva EL, Spirkina ES, Chegurov OK, Reva MA. Lipid peroxidation profile in the synovial fluid of the joints in patients with gonarthrosis, accompanied by defects in the articular surfaces. Science of the Young (Eruditio Juvenium). 2020;8(1):70-5. (In Russ.) doi:10.23888/HMJ20208170-75.
43. Choi WS, Lee G, Song WH, et al. The CH25H-CYP7B1-RORa axis of cholesterol metabolism regulates osteoarthritis. Nature. 2019;566(7743):254-8. doi:10.1038/s41586-019-0920-1.
44. Kabalyk MA, Nevzorova VA, Kovalenko TS. Molecular and cellular mechanisms of osteoarthritis in experimental arterial hypertension and hyperlipidemia. Osteoarthr Cartil. 2019;27(1):S188. doi:10.1016/j.joca.2019.02.286.
45. de Munter W, Geven EJ, Blom AB, et al. Synovial macrophages promote TGF—в signaling and protect against influx of S100A8/ S100A9-producing cells after intra-articular injections of oxidized low-density lipoproteins. Osteoarthr Cartil. 2017;25(1):118-27. doi:10.1016/j.joca.2016.07.020.
46. Harrison C, Henderson J, Miller G, Britt H. The prevalence of complex multimorbidity in Australia. Aust N Z J Public Health. 2016;40(3):239-44. doi:10.1111/1753-6405.12509.
47. 47 Pastraigus C, Ancuta C, Miu S, et al. Knee osteoarthritis, dyslipidemia syndrome and exercise. Rev Med Chir Soc Med Nat Iasi. 2012;116(2):481-6.
48. Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology (Oxford). 2018;57(Suppl4):iv61-74. doi:10.1093/rheumatology/key011.
49. Angeli F, Trapasso M, Signorotti S, et al. Amlodipine and cele-coxib for treatment of hypertension and osteoarthritis pain. Expert Rev Clin Pharmacol. 2018;11(11):1073-84. doi:10.1080/17512433.2018.1540299.
50. Deng C, Bianchi A, Presle N, et al. Eplerenone treatment alleviates the development of joint lesions in a new rat model of spontaneous metabolic-associated osteoarthritis. Ann Rheum Dis. 2018;77(2):315-6. doi:10.1136/annrheumdis-2016-210700.
51. Li Z, Liu B, Zhao D, et al. Protective effects of Nebivolol against interleukin-1 в (IL-ie)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13). Cell Stress Chaperones. 2017;22(6):767-74. doi:10.1007/s12192-017-0805-x.
52. Gierman LM, Kuhnast S, Koudijs A, et al. Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden. CETP mice — a translational model for atherosclerosis. Ann Rheum Dis. 2014;73:921-7.
53. Hosseinzadeh A, Bahrampour Juybari K, et al. Protective effects of atorvastatin on high glucose-induced oxidative stress and mitochondrial apoptotic signaling pathways in cultured chondrocytes. J Physiol Biochem. 2019;75(2):153-62. doi:10.1007/s13105-019-00666-8.
54. Haj-Mirzaian A, Mohajer B, Guermazi A, et al. Statin Use and Knee Osteoarthritis Outcome Measures according to the Presence of Heberden Nodes: Results from the Osteoarthritis Initiative. Radiology. 2019;293(2):396-404. doi:10.1148/radiol.2019190557.
55. Veronese N, Koyanagi A, Stubbs B, et al. Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study. Arthritis Care Res (Hoboken). 2019;71(8):1052-8. doi:10.1002/acr.23735.
56. Khaimenova GS, Babanina MYu, Volchenko GV, et al. Modern look at pharmacotherapy of osteoarthritis accomplished with cardiovascular disease. Wiad Lek. 2016;69(2 Pt 2):180-2.
57. Tanaka T, Matsushita T, Nishida K, et al. Attenuation of osteoarthritis progression in mice following intra-articular administration of simvastatin-conjugated gelatin hydrogel. J Tissue Eng Regen Med. 2019;13(3):423-32. doi:10.1002/term.2804.
Supplementary files
Review
For citations:
Kabalyk M.A., Nevzorova V.A. Cardiovascular diseases and osteoarthritis: general mechanisms of development, prospects for combined prevention and therapy. Cardiovascular Therapy and Prevention. 2021;20(1):2660. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2660
Views:
4281
Email this article 
